泰利克斯制药 TLX
$9.63 +$0.21 (+2.23%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $9.63 0.00%
开盘$9.42
昨收$9.42
当日区间$9.42 – $9.71
成交量311.8K
市值$3.26B
市盈率（TTM）99.3
股息率–
基本面
最新报告季度：ANNUAL, ended Dec 2025
营收$803.79M+55.6% YoY
营业利润$18.05M-67.5% YoY
净利润-$7.13M-121.2% YoY
摊薄每股收益-$0.02-121.6% YoY
自由现金流-$15.08M-1,487.3% YoY
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率53.7%
营业利润率5.3%
净利率3.8%
净资产收益率7.4%
资产收益率2.6%
投入资本回报率6.4%
流动比率2.01
负债/资产比率64.2%
现金及投资$251.91M
总负债$575.95M
净现金（净负债）-$324.04M
营收构成
2025/FY 季度
按业务线
按地区
资产负债表
| 项目 | 2026 Q2 | 2025 ANNUAL | 2025 Q4 | 2025 Q2 | 2024 ANNUAL |
|---|---|---|---|---|---|
| 总资产 | $1.36B | $1.16B | $1.16B | $1.19B | $940.38M |
| 流动资产合计 | $488.02M | $330.28M | $330.28M | $398.01M | $570.12M |
| 现金及现金等价物与短期投资 | $251.91M | $141.87M | $141.87M | $207.16M | $440.00M |
| -现金及现金等价物 | $251.91M | $141.87M | $141.87M | $207.16M | $440.00M |
| 应收款 | $170.39M | $138.37M | $138.37M | $129.52M | $99.65M |
| -应收账款 | $163.56M | $129.20M | $129.20M | $123.63M | $86.93M |
| -应收税款 | $6.83M | $7.88M | $7.88M | $5.89M | $10.96M |
| 存货 | $39.03M | $37.08M | $37.08M | $35.23M | $23.62M |
| 其他流动资产 | $26.69M | – | – | $26.10M | – |
| 非流动资产合计 | $873.83M | $833.71M | $833.71M | $791.94M | $370.26M |
| 固定资产净值 | $129.63M | $115.61M | $115.61M | $74.18M | $33.65M |
| -固定资产原值 | $129.63M | $133.53M | $133.53M | $85.11M | $40.53M |
| 投资及预付款 | $40.41M | $3.68M | $3.68M | $4.06M | $3.77M |
| -可供出售证券 | $40.41M | – | – | – | – |
| 商誉及其他无形资产 | $584.61M | $592.82M | $592.82M | $584.17M | $257.86M |
| -商誉 | $197.51M | $198.99M | $198.99M | $185.81M | $66.59M |
| -其他无形资产 | $387.10M | $393.84M | $393.84M | $398.36M | $191.27M |
| 一年以上递延资产 | $85.30M | $59.35M | $59.35M | $75.77M | $28.92M |
| 其他非流动资产 | $33.89M | $60.90M | $60.90M | $53.76M | $46.06M |
| 负债合计 | $874.18M | $748.61M | $748.61M | $768.01M | $587.44M |
| 流动负债合计 | $242.34M | $231.62M | $231.62M | $298.58M | $205.09M |
| 应付款 | $202.82M | $137.42M | $137.42M | $141.60M | $83.83M |
| -应付税款合计 | $33.85M | $30.74M | $30.74M | $51.74M | $30.09M |
| -其他应付款 | $168.97M | $17.86M | $17.86M | $38.17M | $4.06M |
| 短期债务及融资租赁负债 | $15.42M | $18.66M | $18.66M | $21.06M | $13.31M |
| -一年内到期债务 | $11.51M | $13.11M | $13.11M | $12.69M | $11.76M |
| -一年内到期融资租赁负债 | $3.92M | $5.55M | $5.55M | $8.37M | $1.55M |
| 一年内预提费用 | $520,000.00 | $562,000.00 | $562,000.00 | $896,000.00 | $576,000.00 |
| 一年内递延负债 | $390,000.00 | $11.47M | $11.47M | $4.40M | $6.97M |
| 其他流动负债 | $2.90M | $11.54M | $11.54M | $72.28M | $53.22M |
| 非流动负债合计 | $631.83M | $516.99M | $516.99M | $469.43M | $382.35M |
| 长期债务及融资租赁负债 | $564.44M | $448.45M | $448.45M | $397.19M | $346.85M |
| -长期债务 | $504.88M | $391.91M | $391.91M | $371.48M | $341.81M |
| -长期融资租赁负债 | $59.56M | $56.53M | $56.53M | $25.71M | $5.04M |
| 非流动负债 | $8.56M | $9.18M | $9.18M | $9.33M | $8.53M |
| 一年以上递延负债 | $43.30M | $44.71M | $44.71M | $40.21M | $7.83M |
| 员工福利 | $607,000.00 | $444,000.00 | $444,000.00 | $356,000.00 | $305,000.00 |
| 其他非流动负债 | $14.93M | $14.21M | $14.21M | $22.35M | $18.83M |
| 股东权益合计 | $487.68M | $415.38M | $415.38M | $421.94M | $352.94M |
| 股东权益 | $487.68M | $415.38M | $415.38M | $421.94M | $352.94M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $490.92M | $479.96M | $479.96M | $473.11M | $414.01M |
| 留存收益 | -$110.90M | -$154.54M | -$154.54M | -$150.98M | -$152.91M |
| 不影响留存收益的损益 | -$13.24M | $89.95M | $89.95M | $99.81M | $91.84M |
| 其他权益权益 | $120.89M | – | – | – | – |
| -其他应收款 | – | $1.29M | $1.29M | – | $1.77M |
| 预付资产 | – | $12.96M | $12.96M | – | $6.84M |
| -累计折旧 | – | -$17.92M | -$17.92M | -$10.94M | -$6.88M |
| -长期股权投资 | – | $3.68M | $3.68M | $4.06M | $3.77M |
| 一年以上应收账款 | – | $1.34M | $1.34M | – | – |
| -应付账款 | – | $88.81M | $88.81M | $51.69M | $49.68M |
| 一年内应计费用 | – | $32.61M | $32.61M | $43.71M | $33.05M |
利润表
| 项目 | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| 报告营业总收入 | $803.79M | $516.55M | $332.98M | $108.91M | – |
| 营业总收入 | $803.79M | $516.55M | $332.98M | $108.91M | $3.55M |
| 营业成本 | $377.36M | $180.39M | $123.45M | $44.34M | $1.85M |
| 毛利润 | $426.44M | $336.16M | $209.53M | $64.58M | $1.70M |
| 营业费用 | $408.39M | $280.58M | $174.57M | $115.05M | $73.32M |
| 销售及管理费用 | $237.15M | $152.19M | $89.38M | $59.47M | $29.58M |
| -销售及营销费用 | $141.36M | $72.62M | $39.72M | $29.24M | $4.27M |
| -管理费用 | $95.79M | $79.57M | $49.67M | $30.23M | $25.31M |
| 研发费用 | $171.25M | $127.93M | $85.32M | $54.89M | $24.74M |
| 其他营业费用 | -$12,000.00 | $458,000.00 | -$130,000.00 | $691,864.97 | $15.25M |
| 营业利润 | $18.05M | $55.58M | $34.97M | -$50.48M | -$71.62M |
| 非经营性利息净收入（支出） | -$35.04M | -$17.26M | -$8.41M | -$4.55M | -$3.78M |
| 非经营性利息收入 | $5.83M | $7.18M | $671,000.00 | $680.30 | – |
| 非经营性利息支出 | $40.42M | $24.15M | $8.94M | $4.50M | $3.78M |
| 其他财务成本合计 | $452,000.00 | $292,000.00 | $142,000.00 | $56,464.89 | – |
| 其他收入（支出） | $11.72M | -$407,000.00 | -$23.96M | -$12.06M | $17.07M |
| 证券出售收益 | -$563,000.00 | $11.90M | -$734,000.00 | -$760,575.26 | $1.23M |
| 特殊收益（费用） | $11.05M | -$12.60M | -$23.24M | -$11.37M | – |
| -减：重组及并购费用 | -$11.62M | $13.08M | $22.69M | $11.37M | – |
| -减：资本性资产减值 | $566,000.00 | -$475,000.00 | $550,000.00 | $0.00 | – |
| 其他非经营性收入（支出） | $1.23M | $299,000.00 | $14,000.00 | $61,907.29 | $15.84M |
| 税前利润 | -$5.27M | $37.92M | $2.59M | -$67.09M | -$58.33M |
| 税费 | $1.86M | $4.23M | -$1.61M | $3.71M | $32,620.99 |
| 净利润 | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| 持续经营利润 | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| 归属母公司净利润 | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| 归属普通股股东净利润 | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| 基本每股收益 | -$0.02 | $0.10 | $0.01 | -$0.23 | -$0.21 |
| 摊薄每股收益 | -$0.02 | $0.10 | $0.01 | -$0.23 | -$0.21 |
| 折旧、摊销与折耗 | – | – | – | – | $3.75M |
| -折旧与摊销 | – | – | – | – | $3.75M |
现金流量表
| 项目 | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|
| 投资活动现金流净额 | -$285.92M | -$86.69M | -$16.84M | -$1.30M | -$13.61M |
| 持续经营投资活动现金流净额 | -$285.92M | -$86.69M | -$16.84M | -$1.30M | -$13.61M |
| 固定资产购置及出售净额 | -$25.69M | -$9.12M | -$6.31M | – | – |
| 无形资产购置及出售净额 | -$18.08M | -$13.07M | -$802,000.00 | – | – |
| 业务购买及出售净额 | -$229.03M | -$23.20M | -$995,000.00 | – | – |
| 投资购置及出售净额 | -$892,000.00 | -$32.91M | -$8.70M | – | – |
| 其他投资变动净额 | -$12.22M | -$8.40M | -$37,000.00 | $15.51M | -$13.61M |
| 筹资活动现金流 | -$3.72M | $416.79M | $7.09M | $1.85M | $2.21M |
| 持续经营筹资活动现金流净额 | -$3.72M | $416.79M | $7.09M | $1.85M | $2.21M |
| 债务发行及偿还净额 | -$5.53M | $425.84M | $2.92M | $1.15M | $172,216.58 |
| 普通股发行净额 | $1.81M | $662,000.00 | $4.17M | $5,599.88 | $2.27M |
| 期末现金余额 | $141.87M | $440.00M | $84.30M | $84.30M | $88.32M |
| 现金净变动 | -$306.93M | $357.59M | $4.53M | -$7.42M | $2.33M |
| 期初现金余额 | $440.00M | $84.30M | $78.78M | $88.32M | $84.65M |
| 汇率变动影响 | $8.80M | -$1.89M | $992,000.00 | -$631,848.14 | $1.34M |
| 自由现金流 | -$61.07M | $5.31M | $7.16M | -$15.08M | $13.73M |
| 其他筹资费用净额 | – | -$9.71M | – | – | -$233,263.50 |
暂无评论——快来第一个聊聊 TLX。
登录后参与讨论。